You are viewing the site in preview mode
Skip to main content
|
Characteristics
|
All patients 23 (100%)a
|
NR 7 (30%)
|
PR 10 (43%)
|
TR 6 (26%)
|
p valueb
|
|---|
|
Tumor diff. after treatment
| | | | |
0.064
|
|
No surgery
|
3 (13)
|
0
|
0
|
3 (50)
| |
|
Missing value
|
5 (22)
|
2 (29)
|
1 (10)
|
2 (33)
| |
|
Well
|
5 (22)
|
1 (14)
|
4 (40)
|
0
| |
|
Moderately
|
9 (39)
|
3 (43)
|
5 (50)
|
1 (17)
| |
|
Undifferentiated
|
1 (4)
|
1 (14)
|
0
|
0
| |
|
Post-treatment stage
| | | | |
3.3e−08
|
|
0
|
6 (26)
|
0
|
0
|
6 (100)
| |
|
I
|
7 (30)
|
0
|
7 (70)
|
0
| |
|
IIA
|
3 (13)
|
2 (29)
|
1 (10)
|
0
| |
|
IIIA
|
2 (9)
|
0
|
2 (20)
|
0
| |
|
IIIB
|
2 (9)
|
2 (29)
|
0
|
0
| |
|
IIIB–IIIC
|
3 (13)
|
3 (43)
|
0
|
0
| |
|
ypT
| | | | |
4.6e−08
|
|
T0
|
6 (26)
|
0
|
0
|
6 (100)
| |
|
T1
|
3 (13)
|
0
|
3 (30)
|
0
| |
|
T2
|
6 (26)
|
0
|
6 (60)
|
0
| |
|
T3
|
7 (30)
|
6 (86)
|
1 (10)
|
0
| |
|
T4
|
1 (4)
|
1 (14)
|
0
|
0
| |
|
PNI
| | | | |
1
|
|
+
|
2 (9)
|
1 (14)
|
1 (10)
|
0
| |
|
−
|
21 (91)
|
6 (86)
|
9 (90)
|
6 (100)
| |
|
LVI
| | | | |
0.002
|
|
+
|
8 (35)
|
6 (86)
|
2 (20)
|
0
| |
|
−
|
15 (65)
|
1 (14)
|
8 (80)
|
6 (100)
| |
- LVI lymphovascular invasion, NR non-responders, PNI perineural invasion, PR partial responders, TR total responders, ypT post-treatment tumor
- aFirst number: number of patients; number in parentheses: percentage of patients
- bThe p value is obtained by Fisher’s exact test and is considered significant when p value < 0.05
